Oppenheimer Asset Management Inc. Pfizer Inc Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 328,010 shares of PFE stock, worth $8.53 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

328,010

Previous 328,170 0.05%

Holding current value

$8.53 Million

Previous $9.18 Million 3.38%

% of portfolio

0.12%

Previous 0.12%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$27.7 - $31.39 $4,432 - $5,022	-160 Reduced 0.05%	328,010 $9.49 Million
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $686,516 - $804,468	27,178 Added 9.03%	328,170 $9.18 Million
Q1 2024 May 06, 2024	SELL	$25.89 - $29.73 $301,877 - $346,651	-11,660 Reduced 3.73%	300,992 $8.35 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $1.21 Million - $1.57 Million	-46,306 Reduced 12.9%	312,652 $9 Million
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $397,498 - $464,636	-12,387 Reduced 3.34%	358,958 $11.9 Million
Q2 2023 Aug 02, 2023	SELL	$36.12 - $41.79 $237,525 - $274,811	-6,576 Reduced 1.74%	371,345 $13.6 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $22,649 - $29,486	575 Added 0.15%	377,921 $15.4 Million
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $121,158 - $158,159	-2,902 Reduced 0.76%	377,346 $19.3 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.66 Million - $2.03 Million	37,984 Added 11.1%	380,248 $16.6 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $122,513 - $145,262	-2,633 Reduced 0.76%	342,264 $17.9 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $35,273 - $43,707	-771 Reduced 0.22%	344,897 $17.9 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $2.8 Million - $4.15 Million	-67,798 Reduced 16.4%	345,668 $20.4 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $258,539 - $332,116	-6,587 Reduced 1.57%	413,466 $17.8 Million
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $554,522 - $628,180	15,442 Added 3.82%	420,053 $16.5 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $158,441 - $178,689	4,731 Added 1.18%	404,611 $14.7 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $675,123 - $858,477	20,171 Added 5.31%	399,880 $14.7 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $2.9 Million - $3.41 Million	-91,454 Reduced 19.41%	379,709 $13.9 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $1.31 Million - $1.59 Million	-43,439 Reduced 8.44%	471,163 $15.4 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $1.33 Million - $1.91 Million	49,356 Added 10.61%	514,602 $16.8 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $1.29 Million - $1.46 Million	39,138 Added 9.18%	465,246 $18.2 Million
Q3 2019 Oct 31, 2019	BUY	$32.49 - $42.13 $68,034 - $88,220	2,094 Added 0.49%	426,108 $15.3 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $287,260 - $322,527	-7,768 Reduced 1.8%	424,014 $18.4 Million
Q1 2019 Apr 24, 2019	BUY	$37.5 - $41.2 $29,850 - $32,795	796 Added 0.18%	431,782 $18.3 Million
Q4 2018 Jan 30, 2019	BUY	$38.47 - $43.86 $169,768 - $193,554	4,413 Added 1.03%	430,986 $18.8 Million
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $221,469 - $268,629	-6,425 Reduced 1.48%	426,573 $18.8 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $8.56 Million - $9.13 Million	-259,686 Reduced 37.49%	432,998 $15.7 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $175,313 - $203,387	-5,494 Reduced 0.79%	692,684 $24.6 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $21.6 Million - $23.8 Million	698,178	698,178 $24.9 Million

Others Institutions Holding PFE

# of Institutions

3,271

Shares Held

3.63B

Call Options Held

74.3M

Put Options Held

107M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $146B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Pfizer Inc Transaction History